Androgen Deprivation Therapy and its Impact on Neurological Health
IntroductionAndrogen Deprivation Therapy (ADT) hinders androgen release in prostate cancer, facilitating cancer cell regression and halting disease advancement. Its application has expanded from metastatic to localized prostate cancer.1 Prolonged ADT for androgen suppression triggers a swift drop in androgen, known as ‘Andropause’, which brings about various adverse effects based on dose and duration, including cognitive issues like …
Androgen Deprivation Therapy and its Impact on Neurological Health Read More »









